One study identified ECM protein collagen type XIII alpha 1 chain as a biomarker for the TGFβ-responsive CAF subpopulation that produces chemokines to limit recruitment of dendritic cells and T cells into the tumor nest, thus leading to poor responsiveness to anti-PD1/PDL1 therapy in lung cancer (20). This evidence concerns the gene TGFB1 and neoplasm.